CelineBio is a deep tech startup pioneering a novel approach to rejuvenating the immune system through the generation of longitudinal patient data, and Precision AI to maximize clinical success and extend healthy lifespan in age-related diseases. We envision a world with longer, healthier lives that are accessible to all!
We partner with pharmaceutical/biotechnology/research institutes to maximize treatment efficacy, transform patient outcomes, and optimize clinical success in age-related diseases.
We are partially in Stealth Mode and contact us: hello@celinebio.com if you are interested in learning more about us.
**We are based in US and the two fake profiles from Europe are not part of CelineBio.
Supported by Merck DSS, Merck GHI, Northpond VC, Pear VC PFC Program, Johnson & Johnson Innovation Lab, Texas Medical Center Innovation (TMCi), Harvard Innovation Lab, MIT I-Corps NSF, NVIDIA Accelerator, Microsoft, and others.
Company Details
- Address
- United States, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://celinebio.com/
- HQ
- United States
Celine Biotechnologies Questions
Celine Biotechnologies's website is https://celinebio.com/
Celine Biotechnologies's LinkedIn profile is https://www.linkedin.com/company/celine-bio
Celine Biotechnologies's industry is
Biotechnology Research
Celine Biotechnologies's top competitors are
Igm Biosciences, Inc.,
Deep Forest Sciences,
Andson Biotech,
Cancer Prevention And Research Institute Of Texas,
Gulf Coast Consortia - Research,
Lablink Llc,
Kailera Therapeutics,
Texas Medical Center Innovation Factory,
Alumis,
Cell Bioengines, Inc.
Celine Biotechnologies's categories are Biotechnology Research
